Fubini Ross 4
4 · Ginkgo Bioworks Holdings, Inc. · Filed Jun 13, 2025
Insider Transaction Report
Form 4
Fubini Ross
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2025-06-11+10,822→ 10,822 total - Award
Stock Option
2025-06-12+34,375→ 34,375 totalExercise: $9.29Exp: 2035-06-12→ Class A Common Stock (34,375 underlying) - Exercise/Conversion
Restricted Stock Units
2025-06-11−10,822→ 0 totalExercise: $0.00→ Class A Common Stock (10,822 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]In accordance with the Issuer's Non-Employee Director Compensation Program, the RSUs granted on June 13, 2024 vested in full in Class A shares on June 11, 2025, which was the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, and was subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date.
- [F3]In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 12, 2025, the option shall vest and become exercisable in substantially equal installments on each of the first three anniversaries of the date of grant, such that the option shall be fully vested on the third anniversary of the date of grant, subject to the Non-Employee Director continuing in service as a Non-Employee Director through each such vesting date.